Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, when he plans to make available on the NHS high-tech neuro-protective medication for stroke patients.
We understand that clinical research is ongoing into the effectiveness of neuroprotective agents in minimising the effects of conditions causing neurodegeneration such as traumatic brain injuries, strokes, and dementia.
The Government and the National Health Service supports research into new technologies through the National Institute for Health Research and its clinical research networks.